Archives

by in
Entry Author Date Location
Fierce 15 Shines Light on Some of Our Favorite Companies in Boston and Beyond 09/15/10 National
ImmunoGen and Genentech “Empowered Antibody” Cancer Drug Fails to Garner Accelerated Approval from FDA 08/27/10 Boston
KaloBios, Seeking to Apply Antibodies Beyond Cancer, Sets Sight on Killing Deadly Lung Invader 08/17/10 San Francisco
Genentech Agrees to Pay Seattle Genetics Up to $900M for “Empowered Antibodies” 08/03/10 Seattle
ThredUP Funded by New Micro VC Firm, Visterra Grabs $6M, Vivox Gets $2M From Peacock Equity, & More Boston-Area Deals News 07/14/10 Boston
Femta Pharmaceuticals Snags $2.2M for Potent Antibody Drugs 07/13/10 San Diego
AnaptysBio Gets $1.5M from DARPA 07/12/10 San Diego
AlloCure Arrives in New England, Merck Shutters Cambridge Research Site, Infinity Cuts Deal With Intellikine, & More Boston-Area Life Sciences News 07/09/10 Boston
CMC Icos Mounts Comeback, Resumes Hiring, After Pausing During the Downturn 07/07/10 Seattle
Ablexis Maps Out New Antibody Drug Strategy with $12M From Third Rock, Pfizer 06/23/10 San Francisco
Seattle Genetics’ Dark Horse Drug Candidate Approaches Home Stretch in Leukemia Study 06/22/10 Seattle
Theraclone Sciences CEO David Fanning Dies Suddenly 06/14/10 Seattle
Quanterix Uses Fiber Optics to Find Cancer Protein, Nears New Funding Round 05/27/10 Boston
Signature Genomic Gets Sold for $90M, DreamBox Bought by Netflix CEO, The $7M Madrona Man, & More Seattle-Area Deals News 04/21/10 Seattle
The Hybritech Alumni: Where Are They Now? 03/12/10 San Diego
Seattle Genetics Gets Roche Cash 03/03/10 Seattle
Celldex CEO Treks From NJ to Massachusetts in Pursuit of Antibody Drugs for Cancer 02/23/10 Boston
Google Pours “Incredible” Computing Power into Antibody Drug Discovery With Adimab 02/03/10 Boston
Millennium, In a New Role, Flexes Global Muscle to Cut Deal With Seattle Genetics 01/26/10 Boston
Alnylam Maps Out First Steps in ‘RNA Decade’ 01/11/10 Boston
Alder Rises from Ashes, Seattle Genetics Gets Empowered, ZymoGenetics Nets $79M & More Seattle-Area Life Sciences News 01/07/10 Seattle
Seattle Genetics Maps Out a Future With Antibody Drugs That Are “Empowered” 01/06/10 Seattle
Zulily Gets Funded, Ontela Merges with Photobucket, OncoGenex Secures $60M from Teva, & More Seattle-Area Deals News 12/22/09 Seattle
Adimab Proves Fast Antibody Discovery Tool to Merck, Roche; Snags New Deal With Pfizer 12/17/09 Boston
Roche Scraps Partnership With Seattle Genetics on Lymphoma Drug 12/11/09 Seattle
Facet Rejects Biogen’s Latest Offer 12/10/09 Boston
Biogen Idec’s Dream: Antibodies That Kill Two Birds With One Stone 12/09/09 Boston
Biogen Fattens Offer to Buy Facet Biotech 12/03/09 Boston
Exploring Mountains of Innovation in Northern New England 11/03/09 Boston
Virdante Pharma Lands $30M in A Round to Combat Inflammation 10/29/09 Boston
Page 3 of 4 « previous page · next page »

Xconomy Events Across the Network

XSITE 2013: Boston’s Tech Revival

Boston · 6/19/13
9:00 am

More Xconomy Events

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.